pression may be the only option, even when neurological deficits are severe. 1 In this article, we present the clinical features, risk factors, outcome, and prognostic factors in a series of patients with CVST who underwent decompressive craniectomy. The main objectives of this study were to analyze outcome, along with the various parameters influencing outcome, in patients who underwent decompressive craniectomy for a large unilateral hemorrhagic infarct with impending herniation.
Methods
This study was a retrospective analysis of all patients who underwent decompressive craniectomy for CVST between August 2006 and June 2008 at the National Institute of Mental Health and Neurosciences. A total of 34 patients who underwent decompressive surgery for CVST (unilateral large hemorrhagic infarct) were included. The cases were evaluated for demographic features, clinical features, radiological features, operative findings, and outcome of surgery. Ethical clearance was obtained from the institutional ethics committee.
In this cohort, decompressive craniectomy was performed in patients who had a large unilateral hemorrhagic infarct with mass effect and signs of impending herniation or established herniation, with a gradual deterioration in sensorium in spite of adequate antiedema measures. Depending on the site of involvement, craniectomy and duraplasty were performed with pericranial graft. The craniectomy size for each patient was at least 2 cm larger than the maximum size of the hemorrhagic infarct in all dimensions. Biopsy sampling was performed if there was a doubt in diagnosis, while a hemorrhagic infarct was evacuated only if a mass lesion was suspected or if the brain did not start to pulsate even after an adequately large craniectomy. The data for each patient were obtained from the database of the department. Follow-up data were obtained either through direct clinical evaluation or mailed self-report questionnaire and telephone conversations. The GOS and RDS were used to assess the outcome of patients in the follow-up period.
Results

Patient Population
There were 34 patients in the study; the mean age was 31.6 years, with a range from 18 to 65 years. There were 13 men (38.2%) and 21 women (61.8%), and the ratio was 1:1.6.
Etiological Factors
The predisposing factors to CVST are given in Table  1 ; no cause was identified in 5 patients. Among the 8 patients in the postpartum period, the average time after delivery ranged from 6 to 14 days. One patient had suffered 30% burns and developed CVST during the treatment, and 1 patient developed CVST following assault with penetrating injury. One had CVST secondary to malignancy (carcinoma of the rectum with metastases).
Clinical Profile
The neurological symptoms and signs at admission are summarized in Table 2 . At presentation the GCS score ranged from 4 to 13, with a mean of 8.3 and a median of 8. The GCS score was ≤ 9 (considered coma) in 25 patients (73.5%) at the time of initial evaluation. All patients were started on antiedema measures. The average time for deterioration of the GCS score (when patients were taken for surgery) from the presentation GCS score ranged from 3 to 60 hours (mean 18.2 hours). In most patients, either the deranged bleeding profile or severe anemia that was corrected to an acceptable level prior to surgery or delayed referral added to the time to surgery.
Radiological Features
All patients had a large unilateral hemorrhagic infarct, with midline shift and signs of herniation on CT scans. The anatomical distribution of involvement is summarized in Table 3 . In 15 patients (44.1%) the hemorrhagic infarct was on the right side, and in 19 (55.9%) it was on the left side. The midline shift on CT studies ranged from 5 to 16 mm, with a mean of 10.6 mm. The basal cistern was partially effaced in 23 patients (67.6%) and completely effaced in 11 (32.4%). Delta sign and cord sign were present in 6 patients (17.6%) and were absent in the rest.
Biochemical and Hematological Parameters
An analysis of the hematological parameters showed that the coagulation profile was initially deranged in 6. All patients except 1 had a normal platelet count. The hemoglobin values in the patients ranged from 5.8 to 18 g/ dl, with a mean of 10.6 g/dl. All postpartum patients had a hemoglobin level of < 10 g/dl, and the mean hemogram in this subset was 7.8 g/dl. At the time of presentation, 17 patients (50%) had hemogram < 10 g/dl. Electrolyte imbalance (mainly sodium and potassium) was present in 5 (14.7%) of the patients at presentation. 
Surgical Management
Patients underwent decompressive craniectomy of adequate size, with duraplasty performed with a pericranial graft. Patients who had involvement of noneloquent areas with malignant brain bulge during surgery underwent partial evacuation of the hemorrhagic area to achieve closure ( Figs. 1 and 2 ). During surgery, thrombosed veins on the surface were noted, strengthening the diagnosis in 31 patients (91.2%). The mean duration of surgery was 173 minutes, with a range of 120-270 minutes. The mean blood loss during surgery was 528 ml.
Postoperative Course
The GCS score recorded 6 hours after surgery showed a mean of 7.76, with a range from 3 to 12. Twelve patients (35.3%) showed no improvement in their GCS score, and in 3 (8.8%) there was further deterioration in the score. Forty-eight hours after surgery, 1 patient had died, and in the remaining 33, only 3 (8.8%) had no improvement in their GCS score. The mean GCS score at this time was 10.32 (Table 4) .
Morbidity and Mortality
Systemic and local complications encountered in the postoperative period are summarized in Table 5 . Six patients died; among these, 4 died due to progression of the disease and 2 due to systemic causes. One patient died due to pulmonary infection. The patient who had carcinoma of the rectum died at 4 months follow-up due to multisystem metastasis of his primary malignancy.
Follow-Up Findings
Fifteen patients (53.6% of the 28 surviving) had significant hemiparesis (power < 4) at the time of discharge from the hospital. Speech deficit was present in 12 (42.9%), and 7 had global aphasia; 3 had Broca aphasia whereas 2 patients had Wernicke aphasia. The mean follow-up period in this study was 11.7 months, with a range of 4-22 months. Three patients (10.7%) had a seizure in the follow-up period. All patients were advised to undergo physiotherapy, and patients with speech disturbance underwent speech therapy. Heparin was started in all patients (except 1 patient who had thrombocytopenia) 48 hours after surgery. All patients on heparin were later started on oral anticoagulants. The patients' improvement in the follow-up period was graded according to GOS (1 = death and 5 = good recovery) and RDS scores (Table 6 ). 
Prognostic Factors
Comparisons were made between patients with CVST who died and survivors. Analysis was performed for the outcome "death" with the Fisher exact test for categorical data and the Student t-test for continuous data. We performed a logistic regression analysis (backward method) and calculated odds ratios and 95% confidence intervals for the retained variables associated with the outcome "death" in the multivariate analyses. The specificity and sensitivity of the model for prediction of death were calculated. Data were analyzed with SPSS version 13.0 for Windows. * The mean presentation GCS score was 8.3; the mean GCS score prior to induction was 6.8; and the 6-hour postoperative GCS score was 7.8. There was no change in 12 of 34 patients; scores were worse in 3 of 34; and scores improved in 19 of 34 when GCS score prior to induction was compared with 6-hour postoperative GCS score. By univariate analysis, the GCS scores prior to surgery and in the immediate postoperative period had statistical significance (p < 0.05) to survival. The GCS score prior to surgery had a p value of 0.005, and the immediate postsurgery GCS score had a p value of 0.002 on univariate analysis. Multivariate regression analysis of the various parameters for good outcome (RDS Score 0, 1, or 2) or poor outcome (RDS Score 3, 4, or 5), excluding the patients who had died, was performed. Only the immediate postoperative GCS score (p = 0.031) was a significant predictor of poor outcome (Table 7) .
Discussion
The syndrome of intracranial venous and sinus thrombosis-termed CVST-was recognized in the early part of the 18th century. This disorder has a myriad of etiological factors and is a great masquerader because it can present in various forms and confuse the clinician.
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Cerebral venous sinus thrombosis constitutes 10%-15% of stroke cases in young patients and is the most common cause of stroke in premenopausal women. 13 On the Indian subcontinent, postpuerperal CVST is the most common type, with the clinical picture usually occurring 7-10 days after normal delivery; patients commonly present with severe headache, low-grade fever, unifocal or multifocal seizures, and/or focal neurological deficits of various magnitude and severity. 5, 9 In recent series of adults with CVST, the most common clinical features were related to venous stasis and elevated ICPs. 6 Seizures in 37%-47% of patients and focal neurological signs (in 46%) were associated with ICH. 5 The classic radiological findings on CT scans (preand post-contrast) include the "dense cord" sign representing a thrombosed cortical vein, dense dural sinuses representing an acute thrombosis of the dural sinuses, dense jugular vein representing an acute thrombosis of a jugular vein, and dense triangle or delta sign representing an acute thrombosis of the superior sagittal sinus. Indirect findings suggestive of CVST include nonhemorrhagic or hemorrhagic venous infarcts, multifocal hemorrhages, subdural/subarachnoid hemorrhage, and diffuse cerebral edema. The CT venography modality allows optimal visualization of the venous system.
14 A combination of various sequences (T1, T2, FLAIR, and T2*) on MRI studies along with MR venography are the investigations of choice.
The first line of management choices includes fulldose intravenous heparin or subcutaneous low-molecularweight heparin, along with antiedema measures and other symptomatic measures. There is currently no evidence from randomized controlled trials about the efficacy and safety of either systemic or local thrombolytic therapy in patients with CVST. 6 Thrombolytic therapy has the potential to provide faster restitution of venous outflow, and positive effects of local thrombolytic treatment of CVST have increasingly been reported in uncontrolled series. 7 In severe cases, decompressive surgery may be the only way to save the patient's life. Local thrombolysis may not be a treatment option in such cases because of the incalculable risk of further ICH extension with an additional detrimental effect on ICP. The hemorrhagic infarct should not be removed, because neuronal damage is often less pronounced in CVST-related hemorrhage, which may explain the possible reversibility of even severe clinical symptoms. 14 
Demographic Profile
In our study, age was not a significant factor in either outcome (death or dependency), in contrast to the ISCVT, in which age (> 37 years) was a significant factor in outcome. 10, 13 De Bruijn et al. 9 reported that age > 30 years was a poor prognostic indicator. Male patients had a poorer outcome according to the ISCVT, but in other studies, including ours, it has not been a significant factor.
The main predictors of death within 30 days in the ISCVT were seizure, mental status disturbances, coma (GCS Score ≤ 9), deep CVST, and right hemorrhage and posterior fossa lesions. The total death rate at the end of follow-up in the above-mentioned studies ranged from 0% to 39%. The death/dependence rate at the end of follow-up varied from 9% to 44%, whereas in the ISCVT only 13% of the patients either had died or were dependent at the end of follow-up. Long-term prognostic factors analyzed by multivariate analysis 2,3,10 confirmed coma, cerebral hemorrhage, and malignancy to be important prognostic factors for death or dependence. Diagnostic delay of more than 10 days was also reported as an independent factor playing a role in poor outcome. 9, 10 All studies published to date confirm that coma and cerebral hemorrhage were independent, significant predictors of poor outcome.
Is There a Role for Decompressive Craniectomy in CVST?
All patients in our study had both factors (that is, coma and cerebral hemorrhage) and were neurologically deteriorating despite adequate antiedema measures. Comatose patients may define a subgroup of patients with CVST who are at high risk of death despite antiedema and anticoagulation measures. Local thrombolysis is usually not a treatment option in such cases because of the increased risk of further extension of hemorrhage, with an additional detrimental effect on ICP. In severe cases threatening transtentorial brain herniation due to a unilateral large hemorrhagic infarct, decompressive surgery may be the only option. The hemorrhagic infarct should not be removed, unless absolutely necessary, because neuronal damage is often less pronounced in CVST-related hemorrhage, explaining the possible reversibility of even severe clinical symptoms.
14 No randomized studies exist comparing decompressive craniectomy with other measures to reduce intracranial hypertension (like barbiturate coma) in CVST.
The literature regarding the role of decompressive craniectomy in CVST is scanty. In the Zürich study, 13 15 patients with primary CVST and intraparenchymal hemorrhage were treated. Among them, 4 patients underwent decompressive craniectomy. The mean GCS score immediately before the surgery was 10.2 (range 6-13). All 4 patients who underwent decompressive craniectomy recovered with favorable functional outcome (GOS Scores 4 and 5). Stefini et al. 18 reported on 3 patients with fixed dilated pupils due to transtentorial herniation who underwent decompressive surgery, 2 of whom recovered with only minor neurological sequelae. Coutinho et al. 7 reported on 3 cases and reviewed the literature for 10 cases; a favorable outcome was reported in 11 of 13 cases.
In our study the mortality rate was 6 (17.7%) of 34, which is comparable to other studies that have included all patients with CVST. The percentage of patients with coma in our series was 73.5% at the time of admission and 94.2% at time of surgery. This is in contrast to the 13.9% in the ISCVT 10, 12 and the 15% of de Bruijn et al. However, our study is not strictly comparable to other large series because they have included all patients with CVST.
If death and dependency are taken together as poor outcome, 8 (23.5%) of 34 patients had a poor outcome in our study. This is comparable to other prospective studies with long-term follow-up that have included all patients with CVST and not necessarily only the severe ones, as in our study (Table 8) . Thus, a favorable functional outcome in selected patients with the most severe courses of CVST can be achieved after decompressive craniectomy.
Prognostic Indicators
The surgical factors considered in our study, like the duration of surgery, intraoperative blood loss, and need for blood transfusion, were not statistically significant on univariate and multivariate analysis. The type of surgery (that is, decompressive craniectomy or decompressive craniectomy plus partial evacuation of hemorrhage) did not affect the outcome on analysis. The prominent finding that was noted in this study was that the duration of coma or the time between neurological deterioration and surgery was not of any statistical significance for poor outcome. The side of involvement, the lobes involved, the state of basal cisterns, or the midline shift on CT had no statistical significance for outcome on univariate analysis. The other factor, which was prominent in the study, was that all postpartum patients except 1 had anemia at the time of presentation, with hemoglobin levels as low as 5 g/dl. On analysis, neither postpartum status nor the hemoglobin level correlated with poor outcome. The presence of seizure, focal deficit, or other comorbid conditions did not play a role in outcome on analysis.
On univariate analysis, only the GCS score prior to and 6 hours after surgery correlated with poor outcome. Multivariate analysis revealed that the immediate postoperative GCS score (p = 0.031) was the only independent, significant predictor of poor outcome.
Long-term prognostic factors have been analyzed by multivariate methods in 3 previous studies. The ISCVT confirmed coma, cerebral hemorrhage, and malignancy as important prognostic factors for death or dependence. In addition, males, patients > 37 years of age, those with mental status disorder, thrombosis of the deep cerebral venous system, and CNS infection have an increased risk of death or dependence. Seizures (10%) and new thrombotic events (4%) were the most frequent complications during follow-up.
Conclusions
Decompressive craniectomy in a selected cohort of patients had a good outcome in more than three-quarters of the patients. In univariate analysis, GCS score prior to surgery and in the immediate postoperative period had a statistically significant correlation with poor outcome. Immediate postoperative GCS score was the only inde- pendent, significant predictor of poor outcome on multivariate analysis. In contrast to the available literature, our study focuses only on patients with severe CVST who have undergone surgery. In this study, we have shown that even in patients with severe CVST, timely surgery can provide a good clinical outcome.
